Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.69 is in line with its 5-year average of 8.26, near the low end of its 5-year range (5.09–31.75).
As of the fiscal period ended Tuesday, June 30, 2026. 8.44% above its 12-month average of 7.09.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.69.
CURRENT RATIO
7.69
CURRENT RATIO AVG TTM
7.09
CURRENT RATIO AVG 3Y
7.25
CURRENT RATIO AVG 5Y
8.26
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+8.44%
CURRENT VS 3Y AVG
+6.08%
CURRENT VS 5Y AVG
-6.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+105.13%
vs the sector median at left
Market Cap
$1.54B
Current Ratio
6.77
TTM Avg
5.11
3Y Avg
9.27
5Y Avg
12.43
Market Cap
$1.61B
Current Ratio
4.69
TTM Avg
5.56
3Y Avg
3.02
5Y Avg
3.21
Market Cap
$1.51B
Current Ratio
1.52
TTM Avg
1.81
3Y Avg
2.10
5Y Avg
3.34
Market Cap
$1.62B
Current Ratio
2.91
TTM Avg
2.71
3Y Avg
3.12
5Y Avg
3.05
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | $1.57B | 7.69 | 7.09 | 7.25 | 8.26 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 16.01 | 8.50 | 7.33 | 23.22 |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 6.77 | 5.11 | 9.27 | 12.43 |
| uniQure N.V. (QURE)vs › | $1.61B | 10.01 | 10.09 | 8.82 | 10.31 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | 4.69 | 5.56 | 3.02 | 3.21 |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 5.00 | 2.75 | 2.21 | 2.87 |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 1.64 | 1.40 | 1.84 | 1.88 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 1.52 | 1.81 | 2.10 | 3.34 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 2.91 | 2.71 | 3.12 | 3.05 |
| Septerna Inc (SEPN)vs › | $1.63B | 4.99 | 16.25 | 13.64 | 13.64 |
Current Ratio
7.69
Quick Ratio
7.69
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.69 |
| 2026-03-31 | 8.99 |
| 2025-12-31 | 5.28 |
| 2025-09-30 | 6.53 |
| 2025-06-30 | 6.98 |
| 2025-03-31 | 8.41 |
| 2024-12-31 | 5.81 |
| 2024-09-30 | 5.09 |
| 2024-06-30 | 6.67 |
| 2024-03-31 | 5.43 |
| 2023-12-31 | 6.99 |
| 2023-09-30 | 9.13 |
| 2023-06-30 | 11.28 |
| 2023-03-31 | 8.57 |
| 2022-12-31 | 7.77 |
| 2022-09-30 | 9.19 |
| 2022-06-30 | 10.46 |
| 2022-03-31 | 13.35 |
| 2021-12-31 | 13.37 |
| 2021-09-30 | 20.61 |
| 2021-06-30 | 31.75 |
| 2021-03-31 | 45.04 |
| 2020-12-31 | 25.73 |
| 2020-09-30 | 29.02 |
| 2020-06-30 | 35.41 |
| 2020-03-31 | 39.56 |
| 2019-12-31 | 55.12 |
| 2019-09-30 | 48.14 |
| 2019-06-30 | 50.74 |
| 2019-03-31 | 30.29 |
| 2018-12-31 | 43.03 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
